Home Investors UKI2S

UKI2S

Active VC

Portfolio Active

1

Latest Antiverse

Deal flow

$4.6M

1 round

Unicorns

0

≥ $1B valuation

Founded

—

Latest

—

Antiverse

About UKI2S

Venture capital firm tracking 1 AI investment, with focus on Drug Discovery and GB startups. Total tracked deal flow: $4.6M.

Sector focus

💊 Drug Discovery 1

Geographic focus

Portfolio

1

Antiverse

Generative AI antibody design for challenging and undruggable targets

Co-investors

5

AngelHub

Tensor Ventures

InnoSpark Ventures

Kadmos Capital

i&i Biotech Fund

Recent rounds

1

Seed $4.6M Antiverse